BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 29352109)

  • 61. Dual inhibition of BTLA and PD-1 can enhance therapeutic efficacy of paclitaxel on intraperitoneally disseminated tumors.
    Sun WZ; Lin HW; Chen WY; Chien CL; Lai YL; Chen J; Chen YL; Cheng WF
    J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37463789
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The influence of cyclosporin A on lymphocyte attenuator expression.
    Zeng C; Zhen Y; Shu SA; Wu T; Yi H; Lian ZX; Zhao Y
    J Autoimmun; 2007 Jun; 28(4):234-44. PubMed ID: 17449225
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160.
    Liu W; Chou TF; Garrett-Thomson SC; Seo GY; Fedorov E; Ramagopal UA; Bonanno JB; Wang Q; Kim K; Garforth SJ; Kakugawa K; Cheroutre H; Kronenberg M; Almo SC
    J Exp Med; 2021 Dec; 218(12):. PubMed ID: 34709351
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Age-related changes in the gene expression profile of antigen-specific mouse CD8+ T cells can be partially reversed by blockade of the BTLA/CD160 pathways during vaccination.
    Dawany N; Parzych EM; Showe LC; Ertl HC
    Aging (Albany NY); 2016 Nov; 8(12):3272-3297. PubMed ID: 27922818
    [TBL] [Abstract][Full Text] [Related]  

  • 65. BTLA-HVEM Checkpoint Axis Regulates Hepatic Homeostasis and Inflammation in a ConA-Induced Hepatitis Model in Zebrafish.
    Shi W; Shao T; Li JY; Fan DD; Lin AF; Xiang LX; Shao JZ
    J Immunol; 2019 Nov; 203(9):2425-2442. PubMed ID: 31562209
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Disulfide-Linked Peptides for Blocking BTLA/HVEM Binding.
    Spodzieja M; Kuncewicz K; Sieradzan A; Karczyńska A; Iwaszkiewicz J; Cesson V; Węgrzyn K; Zhukov I; Maszota-Zieleniak M; Michielin O; Speiser DE; Zoete V; Derré L; Rodziewicz-Motowidło S
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963646
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of CD4
    McRae JL; Chia JS; Pommey SA; Dwyer KM
    Nephrology (Carlton); 2017 Jul; 22(7):505-512. PubMed ID: 27517975
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression patterns of B cells in acute kidney transplant rejection.
    Carpio VN; Noronha Ide L; Martins HL; Jobim LF; Gil BC; Külzer AS; Loreto Mda S; Gonçalves LF; Manfro RC; Veronese FV
    Exp Clin Transplant; 2014 Oct; 12(5):405-14. PubMed ID: 25299368
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Soluble B and T lymphocyte attenuator possesses antitumor effects and facilitates heat shock protein 70 vaccine-triggered antitumor immunity against a murine TC-1 cervical cancer model in vivo.
    Han L; Wang W; Fang Y; Feng Z; Liao S; Li W; Li Y; Li C; Maitituoheti M; Dong H; Lai Z; Gao Q; Xi L; Wu M; Wang D; Zhou J; Meng L; Wang S; Ma D
    J Immunol; 2009 Dec; 183(12):7842-50. PubMed ID: 19923459
    [TBL] [Abstract][Full Text] [Related]  

  • 70. CD160 expression defines a uniquely exhausted subset of T lymphocytes in HTLV-1 infection.
    Chibueze CE; Yoshimitsu M; Arima N
    Biochem Biophys Res Commun; 2014 Oct; 453(3):379-84. PubMed ID: 25277889
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation.
    Gandolfini I; Crespo E; Baweja M; Jarque M; Donadei C; Luque S; Montero N; Allesina A; Perin L; Maggiore U; Cravedi P; Bestard O
    PLoS One; 2018; 13(7):e0200696. PubMed ID: 30059561
    [TBL] [Abstract][Full Text] [Related]  

  • 72. BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination.
    Derré L; Rivals JP; Jandus C; Pastor S; Rimoldi D; Romero P; Michielin O; Olive D; Speiser DE
    J Clin Invest; 2010 Jan; 120(1):157-67. PubMed ID: 20038811
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CD160 serves as a negative regulator of NKT cells in acute hepatic injury.
    Kim TJ; Park G; Kim J; Lim SA; Kim J; Im K; Shin MH; Fu YX; Del Rio ML; Rodriguez-Barbosa JI; Yee C; Suh KS; Kim SJ; Ha SJ; Lee KM
    Nat Commun; 2019 Jul; 10(1):3258. PubMed ID: 31332204
    [TBL] [Abstract][Full Text] [Related]  

  • 74. BTLA/HVEM Signaling: Milestones in Research and Role in Chronic Hepatitis B Virus Infection.
    Yu X; Zheng Y; Mao R; Su Z; Zhang J
    Front Immunol; 2019; 10():617. PubMed ID: 30984188
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of the BTLA-HVEM complex in the pathogenesis of breast cancer.
    Hu X
    Breast Cancer; 2024 May; 31(3):358-370. PubMed ID: 38483699
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients.
    Karabon L; Partyka A; Ciszak L; Pawlak-Adamska E; Tomkiewicz A; Bojarska-Junak A; Roliński J; Wołowiec D; Wrobel T; Frydecka I; Kosmaczewska A
    J Immunol Res; 2020; 2020():6545921. PubMed ID: 32775467
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunologic Monitoring of T-Lymphocyte Subsets and Hla-Dr-Positive Monocytes in Kidney Transplant Recipients: A Prospective, Observational Cohort Study.
    Cho JH; Yoon YD; Jang HM; Kwon E; Jung HY; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Won DI; Kim CD
    Medicine (Baltimore); 2015 Nov; 94(44):e1902. PubMed ID: 26554788
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells.
    Boice M; Salloum D; Mourcin F; Sanghvi V; Amin R; Oricchio E; Jiang M; Mottok A; Denis-Lagache N; Ciriello G; Tam W; Teruya-Feldstein J; de Stanchina E; Chan WC; Malek SN; Ennishi D; Brentjens RJ; Gascoyne RD; Cogné M; Tarte K; Wendel HG
    Cell; 2016 Oct; 167(2):405-418.e13. PubMed ID: 27693350
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of Immune Profiles and MicroRNA Expression Profiles in Peripheral Blood Mononuclear Cells of Long-Term Stable Liver Transplant Recipients and Recipients With Acute Rejection Episodes.
    Zhang P; Guo Z; Zhong K; Li Q; Ouyang J; Chen M; Hu A; Jiao X; Zhu X; He X
    Transplant Proc; 2015 Dec; 47(10):2907-15. PubMed ID: 26707312
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Xinfeng Capsule improves cardiopulmonary function of knee osteoarthritis rats by BTLA-HVEM signaling pathway to induce Treg immune tolerance].
    Cheng YY; Liu J; Feng YX; Liu L; Wan L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1133-7. PubMed ID: 23127399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.